Introduction of our board members.
(As of June 23, 2020)

Directors

Isao Teshirogi, Ph.D. Representative Director and President and CEO

▼ Reasons for appointment

Isao Teshirogi became Representative Director and President and CEO in 2008. He has pushed forward with global research and development and expansion of overseas business in Europe and Asia to achieve the goals of the Third Medium-Term Management Plan, and secured the Company’s medium-to-long-term profit foundation through globally competitive drug discovery capabilities and evolution of the Company’s royalty business model. Given the steady achievement of the quantitative targets in the Medium-Term Management Plan, Shionogi Growth Strategy 2020 (SGS2020), which was formulated in FY2014, he carried out an update of SGS2020 in October 2016. As part of that update, he set new quantitative targets from the perspectives of growth, efficiency and shareholder returns. These targets were achieved ahead of schedule, particularly profit targets. Based on these results, we believe that he can make the Company “grow as a drug-discovery based pharmaceutical company,” and therefore we elected him as a Director.

▼ Career summary
April 1982
Joined the Company
January 1999
General Manager, Secretary Office and General Manager, Corporate Planning Department
June 2002
Director of the Company
October 2002
General Manager, Corporate Planning Department
April 2004
Executive Officer and Executive General Manager, Pharmaceutical Research & Development Division
April 2006
Senior Executive Officer and Executive General Manager, Pharmaceutical Research & Development Division
April 2007
Senior Executive Officer
April 2008
Representative Director and President and CEO of the Company (incumbent)
Attended all 13 Board of Directors meetings of FY2019.

Takuko Sawada Director and Executive Vice President and Senior Vice President of Integrated disease care Department

▼ Reasons for appointment

Since her appointment as a Director of the Company in 2015, Takuko Sawada has been responsible for business execution of the Corporate Strategy Division as Senior Vice President of the Corporate Strategy Division and as a Senior Executive Officer. She has also moved Medium-Term Management Plan Shionogi Growth Strategy 2020 (SGS2020) forward, and played a central role in formulating the update of SGS2020 in October 2016. Starting in FY2018, she supervises the Integrated disease care Division, Corporate strategy Division, Pharmaceutical Commercial Division and other operations in her capacity as Vice President of the Company. We therefore elected her as a Director.

▼ Career summary
April 1977
Joined the Company
April 2002
Executive General Manager, Pharmaceutical Development Division
April 2007
Officer and Executive General Manager, Pharmaceutical Development Division
April 2010
Executive Officer and Executive General Manager, Pharmaceutical Development Division
April 2011
Senior Executive Officer and Executive General Manager, Global Development Office
April 2013
Senior Executive Officer and Senior Vice President, Global Development and, Pharmaceutical Development Division
April 2014
Senior Executive Officer and Senior Vice President, Global Pharmaceutical Development Division
April 2015
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
June 2015
Director of the Company and Senior Executive Officer and Senior Vice President, Corporate Strategy Division
October 2015
Senior Executive Officer and Senior Vice President, Corporate Strategy Division, and General Manager, Corporate Planning Department
April 2016
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
April 2017
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
April 2018
Director of the Company and Executive Vice President
Aplil 2020
Director of the Company and Executive Vice President and Senior Vice President of Integrated disease care Department (incumbent)

Attended all 13 Board of Directors meetings of FY2019.

Outside Directors

Keiichi Ando Outside Director(Independent Director)

▼ Reasons for appointment

Keiichi Ando has practical experience as a corporate executive at a financial institution and broad insight on finance. He also coordinated the extremely difficult adjustments between the national government and the governments of Osaka Prefecture and Osaka City for the airport management business of Kansai, which was then at a crossroads, and his experience and insight built the foundation of Kansai Airports, which plays a leading role in the current Kansai economy. Thus, he recognizes the corporate responsibility we should fulfill and makes management decisions with an emphasis on objectivity and impartiality, without bias in favor of corporate executives or specific interested parties. We therefore elected him as an outside director. At Board of Directors meetings, he presents many questions and opinions from the perspective of human resources and the use of assets that are important management resources, and provides appropriate advice about budget planning and management and capital policies, including investments.

▼ Career summary
April 1976
Joined Sumitomo Bank Limited
April 2003
Executive Officer, Sumitomo Mitsui Banking Corporation
April 2006
Managing Executive Officer, Sumitomo Mitsui Banking Corporation
April 2009
Director and Senior Managing Executive Officer, Sumitomo Mitsui Banking Corporation
April 2010
Representative Director and Deputy President and Executive Officer, Sumitomo Mitsui Banking Corporation
April 2012
Representative Director and President, NEW KANSAI INTERNATIONAL AIRPORT COMPANY, LTD
July 2012
Representative Director and President and CEO, NEW KANSAI INTERNATIONAL AIRPORT COMPANY, LTD.
June 2016
Outside Director of the Company (incumbent)
June 2016
Representative Director and President, GINSEN CO., LTD. 
June 2017
Outside Director of Tsubakimoto Chain Co. (incumbent)
June 2019
Outside Director of DAIHEN Corporation (incumbent)
Major concurrent posts

Outside Director, Tsubakimoto Chain Co.

Outside Director, DAIHEN Corporation

Attended all 13 Board of Directors meetings of FY2019.

Hiroshi Ozaki Outside Director(Independent Director)

▼ Reasons for appointment

Hiroshi Ozaki has abundant practical experience and wide-ranging knowledge in corporate management and organizational management as a manager of a company based in Kansai. He also serves as chairman of the Osaka Chamber of Commerce and Industry, and developed and implemented a medium-term plan from FY 2017 aimed at promoting the economic growth of Osaka and Kansai. In the Medium-Term Management Plan, he is focusing on promoting the life science industry. We expect him to draw on this wealth of experience and knowledge to make management judgments with an emphasis on objectivity and neutrality. We therefore elected him as an outside director. At Board of Directors meetings, he presents many advices with respect to our business and marketing, and poses the problems about alliances.

▼ Career summary
May 1972
Joined Osaka Gas Co., Ltd.
June 2000
Director, Osaka Gas Co., Ltd.
June 2002
Director and Tokyo Representative, Osaka Gas Co., Ltd., on loan to the Japan Gas Association
June 2005
Managing Director and General Manager of LNG Terminal and Power Generation Business Unit, Osaka Gas Co., Ltd.
June 2007
Managing Director and General Manager of Commercial & Industrial Energy Business Unit, Osaka Gas Co., Ltd.
April 2008
Representative Director and President, Osaka Gas Co., Ltd.
June 2008
Director, Osaka Gas Chemicals Co., Ltd. (incumbent)
June 2009
Representative Director and President, Operating Executive Officer, Osaka Gas Co., Ltd.
June 2009
Director of OGIS-RI Co., Ltd. (incumbent)
June 2011
Outside Director of Asahi Broadcasting Corporation (incumbent)
April 2015
Representative Director and Chairman, Osaka Gas Co., Ltd. (incumbent)
June 2019
Outside Director of the Company (incumbent)
Major concurrent posts

Representative Director and Chairman, Osaka Gas Co., Ltd.

Outside Director, Asahi Broadcasting Corporation

Attended 10/11 Board of Directors meetings of FY2019.

Fumi Takatsuki Outside Director(Independent Director)

▼ Reasons for appointment

Fumi Takatsuki has not been involved in company management in any way in the past, but we expect her to draw on her giving priority to legal compliance and social norms from a global perspective from her position as an attorney in international corporate law. We therefore elected her as an Outside Director.

▼ Career summary
October 2000
Registration of Attorney at Law
October 2000
Joined Oike Law Offices
December 2003
Joined Anderson Mori & Tomotsune Law Offices
February 2004
Service at Beijing Office of Anderson Mori & Tomotsune Law Offices
April 2006
Joined Oh-Ebashi Law Offices
January 2009
Partner of Oh-Ebashi Law Offices
June 2020
Outside Director of the Company (incumbent)
Major concurrent posts
Partner of Oh-Ebashi Offices

Standing Corporate Auditors

Akira Okamoto Standing Corporate Auditor

▼ Reasons for appointment

Akira Okamoto has served as General Manager of administrative units including the Business Support Center and the Personnel Department, and is well-versed in corporate management. He has been involved in enhancement of the Company’s corporate governance and upgrading and operation of the internal control system as General Manager of the Internal Control Department. He provides appropriate recommendations and advice on management decisions and execution of duties from a neutral point of view as a corporate auditor. Accordingly, we judge that he has the appropriate character and insight to perform the duties of a Corporate Auditor, and elected him as a Corporate Auditor.

▼ Career summary
April 1978
Joined the Company
April 2006
General Manager, Business Support Center
April 2007
General Manager, General Affairs & Personnel Department
April 2008
General Manager, Human Resources Department
April 2011
General Manager, Internal Control Department
June 2015
Standing Corporate Auditor of the Company (incumbent)

Attended all 13 Board of Directors meetings of FY2019.

Attended all 8 Board of Corporate Auditors meetings of FY2019.

Ikuo Kato Standing Corporate Auditor

▼ Reasons for appointment

Mr. Ikuo Kato has served as General Manager of the Development Research Laboratories of the Company and as Representative Director and President and Chairman of subsidiary. He is not only well-versed in research and development, but has insight on corporate management. As Representative Director and President and Chairman of the subsidiary, he offers comments as necessary to the Shionogi Group’s management, and in our judgement, he provides appropriate recommendations and advice on management decisions and execution of duties from a neutral point of view as a corporate auditor. Accordingly, we judge that he has the appropriate character and insight to perform the duties of a Corporate Auditor, and elected him as a Corporate Auditor.

▼ Career summary
October 1988
Joined the Company
April 2007
General Manager, Development Research Laboratories
April 2010
General Manager, Drug Development Research Laboratories
April 2011
General Manager, Drug Development Research Laboratories and Representative Director and President, Shionogi TechnoAdvance Research & Co., Ltd.
April 2013
General Manager, Drug Development Research Laboratories and Representative Director and Chairman, Shionogi TechnoAdvance Research & Co., Ltd.
April 2014
Representative Director and Chairman, Shionogi TechnoAdvance Research & Co., Ltd.
June 2016
Standing Corporate Auditor of the Company (incumbent)

Attended all 13 Board of Directors meetings of FY2019.

Attended all 8 Board of Corporate Auditors meetings of FY2019.

Outside Auditors

Takaoki Fujiwara Outside Auditor(Independent Auditor)

▼ Reasons for appointment

Takaoki Fujiwara has extensive practical experience and a wide range of knowledge as a director of Hankyu Hanshin Holdings, Inc. and a manager of a group company of Hankyu Hanshin Holdings, Inc. For these reasons, we expect that he will reflect his experience in audits of the Company with respect to the appropriateness of the management decisions and execution of duties of the Directors from a wide-ranging perspective as an outside corporate auditor. We therefore elected him as an outside corporate auditor. At Board of Directors meetings and Corporate Auditor meetings, he provides appropriate advice about compliance and human resources from insight of practical experience and wide-ranging knowledge in corporate management, and suggests about performance of directors based on wide-range knowledge.

▼ Career summary
April 1975
Joined Hanshin Electric Railway Co., Ltd.
June 2005
Director, Hanshin Electric Railway Co., Ltd.
June 2007
Managing Director, Hanshin Electric Railway Co., Ltd.
April 2011
Representative Director and President, Hanshin Electric Railway Co., Ltd.
June 2011
Director, Hankyu Hanshin Holdings, Inc.
April 2017
Chairman of the Board of Directors and Representative Director, Hanshin Electric Railway Co., Ltd. (incumbent)
June 2017
Representative Director, Hankyu Hanshin Holdings, Inc. (incumbent)
June 2017
Outside Director, Sanyo Electric Railway Co., Ltd. (incumbent)
June 2018
Outside Corporate Auditor of the Company (incumbent)
Major concurrent posts

Chairman of the Board of Directors and Representative Director, Hanshin Electric Railway Co., Ltd.

Director, Sanyo Electric Railway Co., Ltd.

Attended 12/13 Board of Directors meetings of FY2019.

Attended all 8 Board of Corporate Auditors meetings of FY2019.

Tsuguoki Fujinuma Outside Auditor(Independent Auditor)

▼ Reasons for appointment

Tsuguoki Fujinuma has professional expertise in finance and accounting. He has held the important post of Chairman and Advisor of the Japanese Institute of Certified Public Accountants, as well as a number of public offices, and has extensive experience and broad insight as an outside director and outside corporate auditor. In the past, he has not been involved in company management in any capacity other than as an outside director or outside corporate auditor, but based on his experience as a certified public accountant, we believe that he will be able to carry out audits of the Company with higher quality from the viewpoint of finance and accounting. We therefore elected him as an outside corporate auditor.

▼ Career summary
April 1969
Joined Horie Morita Accounting Firm
June 1970
Joined Arthur & Young Accounting Firm
May 1986
Partner and Representative Partner of Asahi Shinwa Accounting Firm (now KPMG AZSA LLC)
July 1993
Managing Partner of Ota Showa & Co. (now Ernst & Young ShinNihon LLC) (Resignation in June 2007)
May 2000
President of the International Federation of Accountants
July 2004
Chairman and President of the Japanese Institute of Certified Public Accountants
February 2005
Trustee and Vice Chairman of the IFRS Foundation Trustee
July 2007
Advisor of the Japanese Institute of Certified Public Accountants (incumbent)
August 2007
Outside Director of Tokyo Stock Exchange Group, Inc.
October 2007
Governor of Tokyo Stock Exchange Regulation
April 2008
Specially appointed Professor of Chuo Graduate School of Strategic Management
June 2008
Outside Corporate Auditor of Sumitomo Corporation
June 2008
External Outside Corporate Auditor of Takeda Pharmaceutical Company Limited
June 2008
Outside Director of Nomura Holdings, Inc. Outside Director of Nomura Securities Co., Ltd.
July 2008
Outside Director of Sumitomo Life Insurance Company
April 2010
Visiting Professor at Kansai University
May 2010
Outside Corporate Auditor of Seven & i Holdings Co., Ltd. (incumbent)
April 2015
Fellow and Advisory Board Member at Chuo University Business School (incumbent)
July 2017
Auditor, Chiba Gakuen (incumbent)
June 2019
Outside Corporate Auditor of the Company (incumbent)
Major concurrent posts
Auditor, Chiba Gakuen

Attended 11/11 Board of Directors meetings of FY2019.

Attended 6/6 Board of Corporate Auditors meetings of FY2019.

Shuichi Okuhara Outside Auditor(Independent Auditor)

▼ Reasons for appointment

Mr. Shuichi Okuhara is qualified as a certified public accountant and has professional expertise in finance and accounting. We believe that he will be able to carry out audits suitable for the continually changing business environment based on his experience as Board member of Nippon Venture Capital Co., Ltd. in a social environment that places importance on peer or cross-industrial partnerships. We therefore elected him as an outside corporate auditor.

▼ Career summary
April 1994
Joined Andersen Consulting Co., Ltd. (now Accenture Japan Ltd.)
October 1998
Joined Nippon Venture Capital
June 2008
Director and Investment manager of Nippon Venture Capital
April 2009
Representative Director and President of Nippon Venture Capital
June 2019
Representative Director and Chairman of Nippon Venture Capital (incumbent)
June 2020
Outside Corporate Auditor of the Company (incumbent)
Major concurrent posts
Representative Director and Chairman of Nippon Venture Capital (incumbent)

Corporate Officers

Senior Executive Officer
Kohji Hanasaki, Ph.D.
Senior Executive Officer
John Keller, Ph.D.
Senior Executive Officer
Kazuhiro Hatanaka
Senior Executive Officer
Toshinobu Iwasaki, Ph.D.
Senior Executive Officer
Noriyuki Kishida
Senior Executive Officer
Ryuichi Kiyama, Ph.D.
Corporate Officer
Takeshi Shiota, Ph.D.
Corporate Officer
Akira Kato, Ph.D.
Corporate Officer
Yasuyoshi Isou, Ph.D.
Corporate Officer
Tatsumori Yoshida